Intragastric Balloon for the treatment of Obesity.
Intragastric Globe (air filled).
Most studies were performed using liquid-filled balloons. Air-filled balloons may increase digestive tolerance, efficacy of a new air-filled intragastric balloon in nonmorbidly obese patients.
For more endoscopic details, download the video clips by clicking on the endoscopic images. Wait to be downloaded complete thenPress Alt and Enter for full screen.
All endoscopic images shown in this Atlas contain video clips.We recommend seeing the video clips in full screen mode.
Video Endoscopic Sequence 1 of 13.
Intragastric Balloon for the treatment of Obesity
This procedure is totally ambulatory and does not require surgery.
Placement of IGB is carried out in an Endoscopy Suite. Intravenous conscious sedation is administered and the throat is sprayed with local anesthetic. Endoscopic examination of the upper gastrointestinal tract is performed. The scope is then withdrawn. The IGB in its collapsed state is attached to an introducer tube. This ensemble is introduced into the stomach via the mouth. Once it is in the correct position the IGB is inflated with air and the introducer tube detached and removed. The entire procedure takes about 15 or 20 minutes.Patients are carefully monitored during the endoscopic procedure and during recovery until they are fully alert.
Video Endoscopic Sequence 2 of 13.
Intragastric balloon: a temporary treatment for obesity
The upper gastrointestinal tract is visualized immediately prior to insertion of the balloon. The diagnostic endoscopy is performed to define anatomy and to exclude concomitant disease which could preclude the safe and effective use of the device. If the stomach is healthy the balloon is introduced into the stomach.
Video Endoscopic Sequence 3 of 13.
Intragastric balloons are a temporary non-surgical obesity treatment that induces short-term weight loss by partially filling the stomach to achieve satiety and reduce food intake.
Obesity is a chronic metabolic disorder with considerable health risks, which can be approved by a sustained modest weight loss. This can be achieved by medical treatment through behavioral therapy, diet, exercise and pharmacotherapy. Surgery is often needed for the severely obese. Intragastric balloon treatment stands in between, being more drastic than medical treatment but less invasive than surgery.
Video Endoscopic Sequence 4 of 13.
Candidates for IGB
Patients with moderate obesity (BMI 30 40) which places them at serious medical risk.
Patients with severe obesity (BMI >40) who are awaiting definitive surgery (isolated gastric bypass or gastric banding)
Patients with co morbid conditions which make them high risk for surgery or anesthesia who wish to lose weight.
Video Endoscopic Sequence 5 of 13.
IGB Therapy
The inflated IGB stays in the stomach for a maximum of 6 months during which time patients are followed carefully by our medical specialists. In rare circumstances the IGB may have to be removed before the end of the six months. This can be done at any time. While the balloon is in the stomach the patient will experience a felling of fullness (satiety). Because the balloon takes up a lot of space in the stomach less space is available for food. This results in smaller meals and the loss of excess weight. During the six months the average weight loss is 35 lbs. (range 12-42 lbs).
Some patients have lost until 60 lbs.
Video Endoscopic Sequence 6 of 13.
Is a balloon with a triple shell of air molded silicone and both have polymerized interiors totally biocompatible, that permits a better homogeneity with its thickness. This mechanism reduces to a minimum the possibility of migration. The Gastric Balloon is inflated with air and its maximum weight is between 26 and 28 grams. The life expectancy of the Gastric Balloon is between 6 and 7 months, at which time it has to be removed in the same way it was placed with the help of the gastroscope as an ambulatory procedure.
Video Endoscopic Sequence 7 of 13.
Positioning was performed, after diagnostic endoscopy, under unconscious sedation. After placement, the balloon was slowly inflated with 840-960 cc of air, which gives the inflated final volume of 650-700 cc of air, as the air is compressed.
Video Endoscopic Sequence 8 of 13.
It is important to understand that the IGB is an aid to weight loss and must be used in conjunction with a prescribed diet and behaviour modification program. Therefore, the amount of weight lose will depend on how closely follow the diet. How long maintain weight loss will depend on how completely adopt long-term lifestyle changes involving eating behavior and exercise.
Video Endoscopic Sequence 9 of 13.
The Intragastric Balloon is indicated for use for up to six months in patients with a BMI from 30 kg/m2 to 40 kg/m2, who have significant obesity-related health risks.
It is also indicated for use in morbidly obese individuals, defined as those having a BMI >40 or a BMI <35 with serious physiological risks, who refuse surgery or who have a high surgical risk due to their excessive weight.
Weight reduction through the use of the intra-gastric balloon may help to reduce surgical risk before bariatric (weight-loss) or other surgery.
Video Endoscopic Sequence 10 of 13.
The intragastric balloon may be useful when obesity is not severe enough to justify bariatric surgery, or when patients refuse surgery.
The intragastric balloon is less invasive than surgery, can be repeated, and is reversible. Consecutive balloons can potentially be placed to extend treatment. The use of a second balloon was followed by significant weight reduction in a period of 6 months.
Video Endoscopic Sequence 11 of 13.
Abdominal pain, nausea, and vomiting are common, particularly in the first week after balloon implantation.
Lifestyle intervention, including a combination of low-calorie diet, behavioural modification,and physical activity, is recommended for weight loss. Anti-obesity drug therapy may be used as an adjunct to lifestyle intervention.
Video Endoscopic Sequence 12 of 13.
Moderate weight loss may be achieved if patients adhere to a weight-reduction program.
Weight gain can recur when the balloon is removed after six months therefore the patient should be following a diet program.
Obesity appears to lessen life expectancy markedly, especially among younger adults. Obesity increases the risk of premature death from coronary heart disease, stroke, type 2 diabetes, gallbladder disease, and some cancers.
Video Endoscopic Sequence 13 of 13.
The balloon is place immediately after the GE junction.
Plain Abdominal Film
This image shows the space that is occupied by the balloon.